Profusa Inc. (NASDAQ:PFSA) shares soared on Tuesday after the company announced the restructuring of its debt and a reduction in potential shareholder dilution, sparking a wave of speculative buying for the digital health company.PFSA stock is soaring. See the chart and price action here. Debt RestructuringThe primary driver behind the rally was Profusa’s decision to restructure its senior secured convertible notes. The company increased the conversion floor price from 10 cents to 35 cents in a move designe ...

Core Insights - Profusa, Inc. has restructured its Senior Secured Convertible Notes to enhance repayment flexibility and reduce shareholder dilution [1][2] - The conversion floor price has been increased from $0.10 to $0.35, and mandatory amortization payments have been eliminated [2] - The final payment of the notes is due 18 months after issuance, with mandatory payments related to the ELOC increasing from 33% to 50% for shares issued under new registration statements [2] Company Overview - Profusa is a commercial stage digital health company based in Berkeley, California, focused on developing tissue-integrated sensors for continuous monitoring of biochemistry [4] - The company aims to provide personalized biochemical signatures through its long-lasting, injectable biosensors and intelligent data platform [4] - Profusa is led by experienced management and a world-class board, emphasizing its commitment to delivering actionable medical-grade data [4] Management Statements - The CFO of Profusa highlighted the importance of the restructuring in reducing debt and share price dilution, aiming to enhance shareholder value [2] - The CEO expressed excitement about the company's progress towards revenue and the balance sheet restructuring, indicating a focus on accelerating initiatives and developing partnerships [3]

SAN FRANCISCO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference. iRhythm’s management is scheduled to present on Monday, January 12, 2026, at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time. Interested parties may access a live and archived webcast ...

With legacy overhang removed and new capital secured, management shifts focus from balance-sheet repair to disciplined growth execution. West Palm Beach, FL, Dec. 29, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a healthcare technology company focused on digital medicine and population health innovation, today announced the completion of a $500,000 private placement with accredited investors, providing fresh growth capital and further strengthening the Company’s balance sheet followin ...

Core Viewpoint - QHSLab Inc. has successfully completed a $500,000 private placement, enhancing its balance sheet and shifting focus from debt management to disciplined growth execution [1][4]. Financial Restructuring - The company retired over $1.4 million of legacy convertible notes, which had an 18% default interest rate and conversion rights at $0.20 per share, eliminating potential dilution and over $200,000 in annual interest expenses [2][3]. - The combination of eliminating high-cost convertible debt and securing new equity capital has improved the company's liquidity and financial flexibility [3]. Growth Strategy - QHSLab plans to utilize the new capital for targeted sales and marketing efforts, expanding its medical practice client base, onboarding capacity, and customer support activities [3]. - The company aims to increase its physician client base, recurring assessment volume, revenues, and operational efficiencies [3]. Investor Confidence - The recent capital raise was entirely in common stock and long-term warrants, aligning investors with management's long-term growth strategy [4]. - An investor expressed confidence in QHSLab's trajectory, indicating a positive outlook on the company's future [4]. Management Commentary - The President and CEO emphasized that the financing, while modest, marks a significant turning point for the company, allowing it to focus on scaling its digital medicine programs and driving recurring revenue growth [5]. - The company enters 2026 with a cleaner capital structure, positioning it to prioritize disciplined growth and shareholder value [5]. Recent Financial Highlights - For the first nine months of 2025, QHSLab reported revenues of $1.99 million, a 32% increase year-over-year, and a gross profit of $1.32 million, reflecting a 66% gross margin [6].

Rock Health是美国著名的以研究能力见长的专注于数字健康的风险投资机构，他们的研究报告质量非常高，我几乎每期必读。圣诞前他们发布了2026年 数字健康几项热点领域的发展预判，我读后深感对国内奋战在数字医疗领域的同行有价值，特此翻译和解读成文。 01 研究方法：创新成熟度曲线 • 校准阶段 (Calibrating)：创新正在扩展规模，并逐步沉淀进入长期轨道。 • 成熟阶段 (Mature)：最终可能演变为"行业标配"、"利基市场"或消散的"一时热潮"。 这个曲线是通过客观数据评估医疗创新的阶段，而非依赖市场热度。 其分析框架基于三个核心指标：研究活跃度（PubMed 论文量）、风险投资金额（资 本风向标）以及合作伙伴活跃度（商业落地证明）。很像Gartner的hype cycle曲线。 该曲线将创新划分为以下关键节点： • 初创期 (Nascent)：领域刚获得市场早期关注，资本市场活跃水平有限。 • 新兴阶段 (Emerging)：资本活跃水平增加，大型企业开始介入。 • 发展阶段 (Developing)：获得大量资金和关注，但尚未实现规模化应用。 02 热点领域发展预判 患者表型分析与数字孪生 ...

Core Insights - AT&T Inc. partners with Sovato to enhance healthcare access by integrating digital health tools with robust connectivity, aiming to improve care delivery in remote areas [1][9] Group 1: Partnership and Technology - The collaboration allows AT&T to transition from a connectivity provider to a significant technology partner in the healthcare sector [1] - Sovato plans to utilize AT&T's extensive network infrastructure to facilitate remote healthcare services, addressing the shortage of healthcare professionals in rural areas [2] - AT&T Business offers secure connectivity solutions, including 5G and cloud services, which are essential for telehealth and remote patient monitoring [3] Group 2: Impact on Healthcare Delivery - The partnership aims to enhance healthcare efficiency and cost management by improving patient data management and reducing long-term healthcare expenses for employers and insurers [5] - AT&T's reliable performance in remote procedures minimizes downtime and ensures patient safety, enabling Sovato to expand its healthcare solutions rapidly [4] Group 3: Competitive Landscape - AT&T faces competition from Verizon and T-Mobile, both of which are also enhancing their digital health offerings through advanced connectivity solutions [6][7] - Verizon is focusing on using 5G and cloud services to support telehealth and remote patient monitoring, while T-Mobile collaborates with digital health providers to improve access for underserved patients [6][7] Group 4: Financial Performance and Estimates - AT&T's stock has increased by 6.5% over the past year, contrasting with a 5.1% decline in the industry [8] - The company trades at a forward price-to-sales ratio of 1.37, which is lower than the industry average of 1.78 [10] - Earnings estimates for 2025 and 2026 have both risen by 0.5%, now projected at $2.06 and $2.25 respectively [11]

Montreal, Quebec and Irvine, California--(Newsfile Corp. - December 18, 2025) - Greybox Solutions Inc., a leading digital health company specializing in clinically validated chronic care management, today announced the official launch of its first reimbursed chronic care and remote patient monitoring (RPM/CCM) services for senior living in the United States, in partnership with Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF) (FSE: 34Q0) ("QeM"), and Vigilant Care Monitoring LLC founded by Brian Schott, a ...

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly†), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference taking place January 12-15, 2026 in San Francisco, California. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, Executive Vice President & Chief Financial Officer; and. ...

VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) (“Hydreight” or the “Company”), a leading provider of compliant digital health infrastructure and on-demand healthcare services across the United States, is pleased to provide an update on the Company’s recent operational performance and platform activity. Operational Highlights Exceeded 1.3 million in product orders placed ahead of schedule, surpassing our full-year 2025 guidanc ...